PATENT CLAIM ANALYSIS

Application Number: 15763527
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "033000"]

Abstract:
The present invention aims to provide a prophylactic and/or therapeutic agent for scleroderma. The present invention also aims to provide a Th2 promotion inhibitor or a vascular stabilizing agent. Glycyrrhetinic acids and/or salts thereof are applied for prevention of scleroderma, treatment of scleroderma, inhibition of Th2 promotion, or stabilization of blood vessels.

Claim (Index 8):
The method according to  claim 7 , wherein said glycyrrhetinic acids comprise glycyrrhizic acid.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12862980', '15122241', '10966845', '14439885', '11961033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.749030082387892
- 35 USC 102 Novelty (BERT): 0.4994097848555363
- Combined Prediction Score: 0.7240680526346566
- Mean Citation Score: 163.96313400000005
- Max Citation Score: 175.26631
- Similarity Product: 106.23243501904489

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test